The deadly delta strain that had wreaked havoc during the second wave continues to dominate in the third wave of Covid in Karnataka, according to Karnataka Health Minister Dr K Sudhakar.
The European Commission on Friday approved Pfizer's antiviral pill for Covid-19 a day after the region's health regulator endorsed the tablet, a move that will ensure wide availability of the promising treatment to EU member states.
Researchers at IIT Jodhpur have developed an explainable Artificial Intelligence solution to predict Covid-19 from chest x-rays, a move that may help countries struggling with a dearth oftesting kits and processing centres in remote areas.
India's drug regulator has given permission to Bharat Biotech to conduct a phase-3 clinical trial for its intranasal Covid vaccine as a booster dose on participants who have been previously inoculated with SARS-CoV 2 vaccines.
Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral Covid-19 drug molnupiravir was active against the fast-spreading Omicron variant.